PK Modeling & E-R Analysis

PK Modeling & E-R Analysis
Product Description

Model-informed solutions to support FIH dose selection and clinical dose optimization, integrating PK, PD, safety, and efficacy data. Our capabilities include PK modeling, exposure–response (E-R) analysis, and RP2D dose optimization, providing quantitative insights for informed dose decisions throughout clinical development.

Read more Show less

Mithra Biotechnology Inc.

  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Research Organisation
View company profile
Categories
more categories Show less
Specifications
  • Details
    PK Modeling to Support Dose Selection & Optimization
More specifications Fewer specifications

Mithra Biotechnology Inc.

  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Research Organisation
View company profile

More Products from Mithra Biotechnology Inc. (2)

  • Integrated Biosimilar Development Solutions

    Product Integrated Biosimilar Development Solutions

    Comprehensive support for biosimilar development, from protein characterization and analytical similarity assessment to comparative PK studies. Our integrated approach connects analytical and bioanalytical data to support scientific evaluation, regulatory strategy, and efficient clinical development.
  • ADC Solutions

    Product ADC Solutions

    Integrated analytical and bioanalytical solutions for ADC development, covering molecular characterization, conjugation assessment, DAR, payload distribution, and serum/plasma stability. Our bioanalysis capabilities include ADC, total antibody, conjugated antibody, and free payload analysis to support PK a...